Bausch Health Companies Inc. Insider Trading

BHC

Last 12 months

Insiders sold 507K and bought nothing on the open market.

All of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in Aug 2025.

Net open-market

−507K

0 buys · 4 sales

Under a 10b5-1 plan

100%

of the value sold

Insiders who bought / sold

0 / 3

executives and directors

Last open-market buy

Aug 2025

Aug 14, 2025

Get an email when BHC's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 19	Aimee J. Lenar President, US Pharma	Sold10b5-1 plan	36,827	$7.03	259K	9.9%	Form 4
May 19	Frank D. Lee Director	Sold10b5-1 plan	24,456	$5.43	133K	33%	Form 4
Mar 2 – 3	Seana Carson EVP, General Counsel	Sold10b5-1 plan 2 parts	11,276	$5.78 average	65K	1.8%	Form 4
Feb 27	Seana Carson EVP, General Counsel	Sold10b5-1 plan	8,388	$5.95	50K	1.0%	Form 4
Nov 25, 2025	Paulson & CO. Inc. Large holder	Bought	2,500,000	$6.25	$15.6M	3.5%	Form 4
Sep 8, 2025	Seana Carson EVP, General Counsel	Sold10b5-1 plan	13,370	$7.31	98K	2.6%	Form 4
Aug 21, 2025	Frank D. Lee Director	SoldNo plan	15,912	$7.66	122K	18%	Form 4
Aug 14, 2025	John Paulson Director	Bought	34,721,118	$9.00	$312M	96%	Form 4
Aug 11, 2025 – Aug 13, 2025	John Paulson Director	Bought 3 parts	3,243,049	$6.56 average	$21.3M	9.9%	Form 4
Jun 13, 2025	John Paulson Director	Bought	3,564,059	$5.94	$21.2M	12%	Form 4
Jun 10, 2025 – Jun 12, 2025	John Paulson Director	Bought 3 parts	2,788,608	$5.27 average	$14.7M	11%	Form 4
Dec 2, 2024	Seana Carson EVP, General Counsel	Sold10b5-1 plan	440	$8.35	4K	0.1%	Form 4

Aug 1910b5-1 plan
Aimee J. Lenar
President, US Pharma · sold 36,827 at $7.03
259K
9.9% of stake
May 1910b5-1 plan
Frank D. Lee
Director · sold 24,456 at $5.43
133K
33% of stake
Mar 2 – 310b5-1 plan
Seana Carson
EVP, General Counsel · sold 11,276 at avg $5.78
65K
1.8% of stake
Feb 2710b5-1 plan
Seana Carson
EVP, General Counsel · sold 8,388 at $5.95
50K
1.0% of stake
Nov 25, 2025
Paulson & CO. Inc.
Large holder · bought 2,500,000 at $6.25
$15.6M
3.5% of stake
Sep 8, 202510b5-1 plan
Seana Carson
EVP, General Counsel · sold 13,370 at $7.31
98K
2.6% of stake
Aug 21, 2025No plan
Frank D. Lee
Director · sold 15,912 at $7.66
122K
18% of stake
Aug 14, 2025
John Paulson
Director · bought 34,721,118 at $9.00
$312M
96% of stake
Aug 11, 2025 – Aug 13, 2025
John Paulson
Director · bought 3,243,049 at avg $6.56
$21.3M
9.9% of stake
Jun 13, 2025
John Paulson
Director · bought 3,564,059 at $5.94
$21.2M
12% of stake
Jun 10, 2025 – Jun 12, 2025
John Paulson
Director · bought 2,788,608 at avg $5.27
$14.7M
11% of stake
Dec 2, 202410b5-1 plan
Seana Carson
EVP, General Counsel · sold 440 at $8.35
4K
0.1% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch BHC, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with BHC

CompareIntrinsic value

VRTXVertex Pharmaceuticals Incorporated

$549.04+3.44%47

ZTSZoetis Inc.

$89.21+7.49%79

VTRSViatris Inc.

$19.22+1.59%24

REGNRegeneron Pharmaceuticals, Inc.

$930.67-4.39%54

ONCBeOne Medicines Ltd.

$377.78+6.42%65

OGNOrganon & Co.

$13.83-0.14%28

ELANElanco Animal Health Incorporated

$25.31+3.01%46

TEVATeva Pharmaceutical Industries Ltd

$42.13+0.52%46

Held by ETFs

BHC is in 10 US ETFs. The largest of them, with BHC's weight in each:

Spot a number that looks wrong? Check it in BHC's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing BHC

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.